Dr. Brian Howard, MD
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $36,150 | 5 | 39.3% |
| Consulting Fee | $31,375 | 18 | 34.2% |
| Food and Beverage | $16,351 | 388 | 17.8% |
| Travel and Lodging | $7,993 | 30 | 8.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABIOMED | $35,581 | 12 | $0 (2024) |
| CVRx, Inc. | $34,616 | 63 | $0 (2024) |
| Abbott Laboratories | $8,715 | 88 | $0 (2024) |
| Impulse Dynamics (USA) Inc. | $4,344 | 13 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $2,024 | 105 | $0 (2024) |
| Medtronic Vascular, Inc. | $1,412 | 13 | $0 (2020) |
| Daxor Corporation | $765.64 | 4 | $0 (2024) |
| IRRAS USA, Inc. | $682.91 | 1 | $0 (2024) |
| Medtronic, Inc. | $498.57 | 6 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $403.75 | 21 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $42,532 | 86 | ABIOMED ($26,147) |
| 2023 | $26,602 | 75 | CVRx, Inc. ($11,134) |
| 2022 | $6,266 | 51 | CVRx, Inc. ($4,541) |
| 2021 | $7,427 | 25 | CVRx, Inc. ($3,805) |
| 2020 | $617.23 | 21 | Medtronic Vascular, Inc. ($262.45) |
| 2019 | $3,377 | 61 | CVRx, Inc. ($1,498) |
| 2018 | $2,091 | 64 | Abbott Laboratories ($1,211) |
| 2017 | $2,957 | 58 | Medtronic Vascular, Inc. ($1,037) |
All Payment Transactions
441 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | CVRx, Inc. | Barostim Neo System (Device) | Consulting Fee | Cash or cash equivalent | $1,600.00 | General |
| Category: Heart Failure and Hypertension | ||||||
| 12/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $31.84 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/18/2024 | ABIOMED | Impella (Device) | Honoraria | Cash or cash equivalent | $600.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/12/2024 | Impulse Dynamics (USA) Inc. | Optimizer (Device), Optimizer | Food and Beverage | Cash or cash equivalent | $14.16 | General |
| Category: Cardiovascular Device | ||||||
| 12/11/2024 | CVRx, Inc. | Barostim Neo System (Device) | Consulting Fee | Cash or cash equivalent | $1,600.00 | General |
| Category: Heart Failure and Hypertension | ||||||
| 12/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: Cardio-renal | ||||||
| 11/14/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $167.50 | General |
| Category: Heart Failure and Hypertension | ||||||
| 11/13/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $6.78 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/12/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $142.50 | General |
| Category: Heart Failure | ||||||
| 11/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $28.82 | General |
| Category: DIABETES | ||||||
| 11/06/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $21.66 | General |
| Category: Heart Failure and Hypertension | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $27.34 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/01/2024 | ABIOMED | Impella (Device) | Honoraria | Cash or cash equivalent | $13,800.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/01/2024 | ABIOMED | Impella (Device) | Travel and Lodging | In-kind items and services | $515.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/01/2024 | ABIOMED | Impella (Device) | Travel and Lodging | In-kind items and services | $277.94 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/01/2024 | ABIOMED | Impella (Device) | Travel and Lodging | Cash or cash equivalent | $32.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/01/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/31/2024 | CVRx, Inc. | Barostim Neo System (Device) | Consulting Fee | Cash or cash equivalent | $7,200.00 | General |
| Category: Heart Failure and Hypertension | ||||||
| 10/25/2024 | CVRx, Inc. | Barostim Neo System (Device) | Travel and Lodging | Cash or cash equivalent | $86.33 | General |
| Category: Heart Failure and Hypertension | ||||||
| 10/18/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $97.31 | General |
| Category: Heart Failure | ||||||
| 10/15/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $22.75 | General |
| Category: Cardiology | ||||||
| 10/14/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $17.71 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/08/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $29.46 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/07/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $162.97 | General |
| Category: Renal Denervation System | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 194 | 413 | $124,828 | $34,704 |
| 2022 | 9 | 203 | 984 | $197,436 | $63,217 |
| 2021 | 11 | 280 | 615 | $140,473 | $50,721 |
| 2020 | 10 | 245 | 497 | $95,470 | $33,308 |
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 60 | 128 | $36,099 | $9,084 | 25.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 25 | 65 | $17,085 | $6,127 | 35.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 12 | 35 | $20,685 | $6,008 | 29.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 33 | 56 | $21,626 | $5,918 | 27.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 27 | 27 | $13,099 | $3,923 | 29.9% |
| 93750 | Evaluation of lower heart chamber assist device | Facility | 2023 | 15 | 80 | $11,120 | $2,444 | 22.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 22 | 22 | $5,114 | $1,200 | 23.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 17 | 123 | $68,557 | $21,416 | 31.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 25 | 163 | $36,861 | $13,203 | 35.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 28 | 71 | $22,311 | $7,632 | 34.2% |
| 93750 | Evaluation of lower heart chamber assist device | Facility | 2022 | 17 | 240 | $29,237 | $7,483 | 25.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 46 | 89 | $19,960 | $6,581 | 33.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 15 | 17 | $6,897 | $2,685 | 38.9% |
| 93793 | Anticoagulant management of patient taking warfarin | Facility | 2022 | 13 | 214 | $5,213 | $1,854 | 35.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 30 | 39 | $6,314 | $1,819 | 28.8% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2022 | 12 | 28 | $2,086 | $543.87 | 26.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 38 | 109 | $22,127 | $8,936 | 40.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 33 | 76 | $22,010 | $8,760 | 39.8% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 17 | 49 | $26,803 | $8,606 | 32.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 51 | 94 | $20,210 | $7,300 | 36.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 23 | 26 | $10,322 | $4,200 | 40.7% |
| 93750 | Evaluation of lower heart chamber assist device with physician analysis | Facility | 2021 | 13 | 97 | $10,476 | $2,992 | 28.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 35 | 63 | $9,261 | $2,833 | 30.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 15 | 39 | $5,499 | $2,185 | 39.7% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2021 | 27 | 31 | $4,836 | $1,675 | 34.6% |
About Dr. Brian Howard, MD
Dr. Brian Howard, MD is a Advanced Heart Failure and Transplant Cardiology healthcare provider based in Marietta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/25/2009. The National Provider Identifier (NPI) number assigned to this provider is 1982832267.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Howard, MD has received a total of $91,869 in payments from pharmaceutical and medical device companies, with $42,532 received in 2024. These payments were reported across 441 transactions from 36 companies. The most common payment nature is "Honoraria" ($36,150).
As a Medicare-enrolled provider, Howard has provided services to 922 Medicare beneficiaries, totaling 2,509 services with total Medicare billing of $181,949. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Practice Information
- Specialty Advanced Heart Failure and Transplant Cardiology
- Location Marietta, GA
- Active Since 06/25/2009
- Last Updated 10/31/2019
- Taxonomy Code 207RA0001X
- Entity Type Individual
- NPI Number 1982832267
Products in Payments
- Impella (Device) $35,581
- Barostim Neo System (Device) $34,616
- OPTIMIZER (Device) $3,910
- HeartMate 3 Left Ventricular Assist Device (Device) $3,266
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $2,198
- ENTRESTO (Drug) $1,803
- HeartWare HVAD (Device) $1,412
- HeartMate II LVAS (Device) $1,066
- Circulatory Support (Device) $980.39
- BVA-100 (Device) $765.64
- Optimizer (Device) $433.38
- HeartMate 3 Left Ventricular Dev (Device) $400.70
- ORENITRAM (Drug) $341.29
- CardioMEMS HF System (Device) $300.74
- BRILINTA (Drug) $281.29
- JARDIANCE (Drug) $240.68
- PIPELINE (Device) $228.33
- HeartMate (Device) $220.13
- INJECTAFER (Drug) $205.38
- LEQVIO (Drug) $200.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.